ItaloPorto2 Profile Banner
Italo Porto Profile
Italo Porto

@ItaloPorto2

Followers
4K
Following
507
Media
19
Statuses
203

Interventional Cardiologist | Full Professor of Cardiology | University of Genova, Italy @UniGenova. All views expressed are my own

Genova, Italy
Joined November 2018
Don't wanna be here? Send us removal request.
@JCM_MDPI
JCM MDPI
5 months
#mdpijcm #HighAltmetricScore #Editor’s Choice Paper🔍 #Aspirin in Primary #Prevention: Looking for Those Who Enjoy It by Roberta Della Bona et al. 🙌 https://t.co/srGQORauM8
0
2
5
@EAPCIPresident
EAPCIPresident
6 months
#EAPCi at @escardio Cardio-Oncology 2025 in 🇮🇹 ⭐️great debate on management of #CAD in patients with active cancer ⭐️#revascularization in #ACS & #CCS PRO & CON #accesstocare #patientcentricapproach @mmamas1973 @ItaloPorto2 @dimario53790
2
8
39
@ItaloPorto2
Italo Porto
6 months
title
Tweet card summary image
primocanale.it
0
0
2
@AntonioMariaLe2
Antonio Maria Leone
8 months
#FullPhysiology at CHANGE in Cardiology 2025. Thanks to the organisers @FullPhysiol @ItaloPorto2
0
4
19
@mmamas1973
Mamas A. Mamas
8 months
@giuseppe_ando with a great presentation around lms revascularisation- when considering outcomes need to consider what we think is important and what patients place greater emphasis on @giuseppemusum11 @ItaloPorto2 Great meeting change in cardiology
0
2
4
@RoccoVergallo
Rocco Vergallo
10 months
“Vulnerable or High-Risk Plaque: A JACC Cardiovascular Imaging Position Statement” just published in @JACCJournals https://t.co/IEi6zHaTUU #atherosclerosis #vulnerableplaque #highriskplaque #imaging #OCT #IVUS #NIRS #deepOCT #CT #PCCT #MRI #lipid #lipidlowering #PCI #outcome
3
70
214
@ehj_ed
EHJ Editor-in-Chief
11 months
Full Physiology for evaluation of intermediate coronary stenosis: it's time for less events, less symptoms and less costs! https://t.co/wGzIVJLfrd #EHJ #fullphysiology #coronary #atherosclerosis #stenosis @ESC_Journals @escardio #cardiotwitter @AntonioMariaLe2
0
14
40
@ItaloPorto2
Italo Porto
11 months
📅 1st February 2025 📍 Hotel Continental, Genoa 🌟 Highlights: 🔹 Advances in managing uncontrolled hypertension 🔹 Renal denervation: guidelines, procedures, and future perspectives 🔹 Expert roundtable on hospital-to-community care https://t.co/OZtJaiRwAs #Hypertension
1
0
2
@SanMartino_Ge
Ospedale San Martino Genova
11 months
Al @SanMartino_Ge arruolato il primo paziente italiano, il secondo europeo, nello studio di fase 3 MAGNITUDE: progetto internazionale che studia l'efficacia di una terapia genica che potrebbe curare definitivamente l'Amiloidosi Cardiaca da Transtiretina. https://t.co/iDWidJN9DC
0
2
5
@Ale_MM1988
Alessandro Mandurino Mirizzi
1 year
Our network metanalysis (42 RCTs, 30219 pts) comparing OCT, IVUS, FFR, iFR, angio for guidance to PCI, updated w/ the latest RCTs, on @IJCardio: 🔸OCT, IVUS, FFR ⬇️cardiac death vs angio 🔸OCT, IVUS ⬇️TLF, TVR, TLR, ST vs angio 🔸OCT ⬇️TLF vs FFR and iFR. https://t.co/gYVj8h5vqk
0
9
20
@sbrugaletta
Salvatore Brugaletta
1 year
A patient-centered approach in management of stable angina, thank to @RoccoMontone @Riccardo_Rin for their coordinating central role in this very useful state-of-the-art review in @JACCJournals @sicigise @ItaloPorto2 @BURZOTTA_F @hospitalclinic https://t.co/lLB3N2J5Md
1
12
46
@EuroInterventio
EuroIntervention
1 year
Targeting inflammation in atherosclerosis: overview, strategy and directions This review by @ron_wasman, @ItaloPorto2 et al. explores inflammation mechanisms in atherosclerosis, potential biomarkers, therapeutic options and future advancements. #eapci https://t.co/lXu0qZWDZQ
1
14
44
@BenenatiStefano
Stefano Benenati
1 year
Proud to share our view on #INOCA and the interplay between invasive and non-invasive diagnostic techniques for diagnosing it. https://t.co/HtbSzTDZ9A
2
4
16
@BenenatiStefano
Stefano Benenati
2 years
Meeting di altissimo profilo scientifico in una cornice mozzafiato. Outstanding meeting in a breathtaking venue. Grazie a // thanks to @giuseppemusum11 @Amgen @ItaloPorto2 #strikearlystrikestrong #pcsk9i
0
1
11
@JAHA_AHA
JAHA
2 years
Study finds 54% 1-year mortality for patients needing renal therapy post-TAVR. Key predictors include advanced CKD, anemia, diabetes, and nonfemoral access. TRITAVI scores can support prevention. #AHAJournals @ItaloPorto2 @saia_francesco @ignamatsant https://t.co/3tRCl3ALwZ
0
4
10
@MattiaGalli10
Mattia Galli
2 years
@EditorEHJCVP
EHJ-CVP Editor-in-Chief
2 years
🔍A journey into the pleiotropic effects of ticagrelor in this elegant study exploring the effects of ticagrelor vs clopidogrel on ischemic preconditioning assessed by intracoronary-ECG: the TAPERS randomized study🎯 https://t.co/FRYfTajYGe #EHJPharmacotherapy @Ricky_Turgeon
0
4
13
@ItaloPorto2
Italo Porto
2 years
0
0
6
@alaide_chief
chief
2 years
#FullPhysiology describing our journey with #INOCAIT @SanRaffaeleMI @SRCathLab ⭐️raising awareness & networking with clinical cardiologists on #INOCA ⭐️building up a stepwise approach to provide a full diagnosis & tailored therapy to our #CCS patients #Teamwork #networking
0
6
24